Leerink Partners Initiates Coverage On Insulet with Outperform Rating, Announces Price Target of $184
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners analyst Mike Kratky has initiated coverage on Insulet (NASDAQ:PODD) with an Outperform rating and a price target of $184.
October 16, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Insulet (NASDAQ:PODD) has been initiated with an Outperform rating by Leerink Partners, with a price target of $184.
The Outperform rating from Leerink Partners indicates a positive outlook for Insulet. The price target of $184 suggests a significant upside potential from the current price. This could lead to increased investor interest and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100